Regenerative Cell Therapy for Hearing Loss: Rincell-1 from Rinri Therapeutics

Can regenerative medicine move beyond managing symptoms to actually restore natural hearing?

Brian Taylor speaks with Simon Chandler, CEO of Rinri Therapeutics, about the company’s pioneering cell therapy for hearing loss. They discuss Rincell-1, Rinri’s first-in-human clinical trial, and how regenerative medicine could complement or even surpass today’s treatments like hearing aids and cochlear implants.

The conversation also explores Rinri’s innovative surgical delivery approach, trial design, and future pipeline, including next-generation therapies aimed at restoring hair cells. Chandler shares his vision for how regenerative medicine could reshape hearing care and open the door to restoring hearing for millions worldwide.

Learn more about Rinri and Rincell-1 at: https://www.rinri-therapeutics.com

Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X.
https://x.com/WeekinHearing
  / thisweekinhearing  
  / this-week-in-hearing  

Visit us at: https://hearinghealthmatters.org/this...

Audio podcast can be found on all major platforms, including Apple & Spotify: https://podcasters.spotify.com/pod/sh...


TIMESTAMPS
00:00 – Introduction
00:50 – Rinri Therapeutics: Origins and Background
03:10 – What Is Rincell-1?
05:13 – Positioning Within Current Treatments
09:50 – Therapeutic Delivery
11:20 – First-in-Human Clinical Trial
14:15 – Timeline and Next Steps
16:30 – Future Pipeline
18:14 – Closing Thoughts